Search

In a new paper in Viruses, Fedor Zurabov (MicroMir, Russia) and colleagues report that phage cocktails were safely administered to thirty patients after COVID-19.

Bennett J. Davenport et al. published a new paper in npj Vaccines entitled Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease.

Paper: Phage-like particle vaccines are highly immunogenic and protect against pathogenic coronavirus infection and disease.

Review: Phage therapy in the COVID-19 era: Advantages over antibiotics.

Daniela Staquicini (Rutgers Cancer Institute of New Jersey) and colleagues published a new paper in PNAS on the design and proof of concept of two phage-based, cold-free COVID-19 vaccination strategies. They show that aerosol vaccination wi

Cytophage Technologies, a Canadian phage biotech company, is about to start testing on animals a throat and nasal spray that would stop infection by COVID-19 and its variants. The idea is that the synthetic phage in their spray will stimula

Animals in the wild have learned to live with 'their' viruses, but humans are still learning. Harald Brussow (KU Leuven) has described in a new 'crystal ball' article how phages have dominated all natural habitats, and has provided a unique

Adaptive Phage Therapeutics (APT) is working toward a phage-based COVID vaccine — a phage engineered to express epitopes of SARS-CoV2 on the surface of the capsid. Phage-based vaccines are attractive because they are considered safe in the

Earlier this month we posted that Adaptive Phage Therapeutics received emergency FDA authorization to treat a group of COVID-19 patients in Texas with A. baumannii infections. Now, they've received expanded access authorization to use their

Adaptive Phage Therapeutics has deployed their PhageBank™ in Texas to treat COVID-19 patients suffering from life-threatening carbapenem resistant Acinetobacter baumannii (CRAB). Eight of these patients have so far received PhageBank™ thera

Li Deng's lab at Helmholtz Zentrum and Technical University of Munich is looking for a highly motivated postdoc with a strong background in synthetic biology to work on a newly founded COVID-19 project. The successful candidate will constru

Andrzej Górski (Polish Academy of Sciences) and colleagues published a new perspective in Future Medicine discussing phages in the fight against COVID-19. They describe research done in the last 15 years pointing to phage interference with

US phage therapy company Adaptive Phage Therapeutics has received a $9.8-million Department of Defense Award to develop phage-based vaccine candidates against SARS-CoV-2.

The PhageOption 2020 meeting scheduled to take place in Cartagena, Colombia, in November has been postponed to 2022.

Interested in how phages could be useful in the COVID-19 battle? Here are a couple of opinions on this: one by Marcin Wojewodzic (Cancer Registry of Norway), published in PHAGE journal, and one by health and science journalist Helen Albert,

The Academy of Finland has granted 10 million Euro for research into COVID-related projects, and part of that will fund phage work! Researchers at the University of Jyväskylä and University of Helsinki in Finland were awarded funding for a

Jameel Ahmad Khan, PhD, Head R&D (IVD-Division), Trivitron Healthcare I am working on a COVID-19 RNA isolation kit. We are observing huge lab to lab variations in RNA yield among Pathology labs. Therefore, I am planning to use RNA phage Par

Jameel Ahmad Khan, PhD, Head R&D (IVD-Division), Trivitron Healthcare I am working on a COVID-19 RNA isolation kit. We are observing huge lab to lab variations in RNA yield among Pathology labs. Therefore, I am planning to use RNA phage Par

Maryn McKenna wrote a new Wired piece on how the COVID crisis may worsen the AMR crisis. Within it, she links to a useful compendium of literature on secondary infections and AMR in the context of COVID-19, which was compiled by two researc

Maryn McKenna wrote a new Wired piece on how the COVID crisis may worsen the AMR crisis. Within it, she links to a useful compendium of literature on secondary infections and AMR in the context of COVID-19, which was compiled by two researc